| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:(±)-ORG 28611
CAS:784138-08-5
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
| Company Name: |
ChemeGen(Shanghai) Biotechnology Co.,Ltd.
|
| Tel: |
18818260767 |
| Email: |
sales@chemegen.com |
| Products Intro: |
Product Name:(±)-ORG 28611
CAS:784138-08-5
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:(±)-ORG 28611
CAS:784138-08-5
|
|
| | (±)-ORG 28611 Basic information |
| Product Name: | (±)-ORG 28611 | | Synonyms: | (±)-ORG 28611;[1-(cyclohexylmethyl)-7-methoxyindol-3-yl]-(3,4-dimethylpiperazin-1-yl)methanone | | CAS: | 784138-08-5 | | MF: | C23H33N3O2 | | MW: | 383.527 | | EINECS: | | | Product Categories: | | | Mol File: | 784138-08-5.mol |  |
| | (±)-ORG 28611 Chemical Properties |
| solubility | DMF: 10 mg/ml; DMSO: 2 mg/ml; Ethanol: 20 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml | | form | A crystalline solid |
| | (±)-ORG 28611 Usage And Synthesis |
| Description | (±)-ORG 28611 is the racemic mixture of the water soluble, full agonist of the human cannabinoid (CB) receptors central CB1 (pEC50 = 7.6; pKi = 8.9) and peripheral CB2 (pKi = 8.8). ORG 28611 (0.1-1 μM/kg, intravenous) demonstrated antinociceptive activity in the mouse tail flick test and the mouse formalin paw test, and it was further evaluated clinically for use as a potential intravenous analgesic agent. | | Uses | (±)-ORG 28611 is full agonist of the human cannabinoid (CB) receptors central CB1 (pEC50 = 7.6; pKi = 8.9) and peripheral CB2 (pKi = 8.8). ORG 28611 (0.1-1 μM/kg, intravenous) demonstrated antinociceptive activity in the mouse tail flick test and the mouse formalin paw test, and it was further evaluated clinically for use as a potential intravenous analgesic agent. Synthetic Cannabinoids |
| | (±)-ORG 28611 Preparation Products And Raw materials |
|